BOSTON, March 2, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced the official launch of Ginkgo Cloud Lab. This new interface allows researchers to transition their benchwork to Ginkgo ...
BOSTON, Feb. 5, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced it has demonstrated, in collaboration with OpenAI, an AI system that autonomously designed, executed, and learned from ...
Jason Kelly, chief executive of Ginkgo Bioworks, spent a surprising amount of time on an earnings call with analysts last week talking about transportation, riding subways, and self-driving cars. “If ...
For the fourth quarter of 2025, Ginkgo Bioworks reported a strategic pivot towards robotics and AI, with CEO Jason Kelly emphasizing the company’s collaboration with the Department of Energy and ...
Includes $0.9 million and $0.4 million in employer payroll taxes for the three months ended March 31, 2026 and 2025, respectively. Represents transaction and integration costs directly related to ...
Hosted on MSN
Ginkgo Bioworks reaffirms $167M-$187M 2025 revenue target as AI-driven automation and tools expansion accelerate
Earnings Call Insights: Ginkgo Bioworks Holdings, Inc. (DNA) Q3 2025 Jason Kelly, Founder, CEO & Director, emphasized Ginkgo’s mission to "make biology easier to engineer" and outlined three major ...
"In 2026, our focus will be on investing to win the category of autonomous labs" (CEO Jason Kelly), adding that Ginkgo’s two main actions are "to take our services...and run them on top of our ...
Ginkgo Bioworks Holdings Inc (NYSE:DNA) is one of the best small cap agriculture stocks to buy now. Ginkgo Bioworks is developing an autonomous lab that it calls Nebula. Biotech companies can use this ...
Good evening. I'm Daniel Marshall, Senior Manager of Communications and Ownership at Ginkgo. I'm joined by Jason Kelly, our Co-Founder and CEO; and Steve Coen, our CFO. Thanks, as always, for joining ...
Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It ...
Nearly two decades ago, four graduate students from MIT united around a shared idea. "We believed that programming cells would ultimately be more important than programming computers," says Jason ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results